Latest Headlines

  1. Sherlock Biosciences Announces Research Collaboration With Dartmouth-Hitchcock Health To Launch Study Of CRISPR-Based Test For SARS-CoV-2 8/12/2020

    Sherlock Biosciences, an Engineering Biology company dedicated to making diagnostic testing better, faster and more affordable, today announced a research collaboration with Dartmouth-Hitchcock Health (D-HH) to launch a clinical study of the Sherlock CRISPR SARS-CoV-2 kit for the detection of the novel coronavirus that causes COVID-19

  2. Precision Pathology Services And bioAffinity Technologies Announce Initiation Of CLIA Validation For Non-Invasive Early Lung Cancer Test 8/12/2020

    bioAffinity Technologies, a privately held biotech company advancing cutting-edge cancer diagnostics, and Precision Pathology Services, a CAP/CLIA-certified anatomic and clinical pathology laboratory, announced initiation of CLIA validation for CyPath Lung, a non-invasive flow cytometric test for early-stage lung cancer

  3. Altitude Lab Brings New Generation Of Biotech Development To Utah 8/11/2020

    Altitude Lab announced its first resident companies and opened applications for its breakthrough collaborative facility and program

  4. USF Connect’s Tampa Bay Technology Incubator Propels Homegrown Researchers At Biotech Startup Psilera Bioscience 8/11/2020

    Psilera Bioscience (“Psilera”) has joined the Tampa Bay Technology Incubator, part of USF Connect (together the “Incubator”) at the University of South Florida (“USF”). The Incubator allows access to laboratories and fosters collaboration within the university to expedite developments toward commercialization

  5. Instrumentation Laboratory Awarded 2020 IMV ServiceTrak Awards For Best System Performance, Service And Customer Satisfaction 8/10/2020

    Instrumentation Laboratory (IL) has received three IMV ServiceTrak Awards for 2020, including Best System Performance, for the second consecutive year, Best Service in the Coagulation category, and Best Customer Satisfaction, in the newly added Blood Gas category

  6. Sysmex America Signs Exclusive Agreement To Distribute And Service Siemens Healthineers Automated Urine Chemistry Analyzer 8/10/2020

    Sysmex America, Inc., a leading diagnostic solutions company offering hematology, urinalysis, information systems and flow cytometry testing technology for optimal clinical laboratory performance, announced an exclusive agreement with Siemens Healthineers that grants North American rights to distribute and service Siemens Healthineers CLINITEK Novus Automated Urine Analyzer for hospital and reference laboratory use

  7. AnPac Bio Validating Approved COVID-19 Antibody Test 8/7/2020

    AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”), a biotechnology company with operations in China and the United States announced today that the Company has been validating an approved COVID-19 antibody test, which has received the FDA’s Emergency Use Authorization, for commercial use in its San Jose, California lab since the second quarter of 2020, with expected validation completion in the second half of 2020

  8. Biocept Announces Agreement With Aegea Biotechnologies To Develop New, Highly Sensitive PCR-Based COVID-19 Assay Utilizing Patented Switch-Blocker PCR Technology 8/6/2020

    Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information to improve the outcomes of patients with cancer, and Aegea Biotechnologies, Inc., an innovative private life science company with an extensive portfolio of issued patents in next-generation nucleic acid technologies, announce a development agreement focused on the co-development by Biocept and Aegea of a highly sensitive PCR-based assay designed by Aegea for detecting the COVID-19 virus

  9. Fujirebio Diagnostics Announces Initiation Of Clinical Testing For The Fully Automated Lumipulse SARS CoV-2 Antigen Assay 8/5/2020

    Fujirebio Diagnostics, Inc., a consolidated subsidiary of H.U. Group Holdings, Inc., announced today the initiation of clinical testing needed for the submission of its new SARS-CoV-2 Antigen assay for EUA (Emergency Use Authorization) from the U.S. Food and Drug Administration

  10. Sysmex-Inostics Colorectal Cancer Blood-Based OncoBEAMTM RAS CE-IVD Test Shows Concordance With Standard Of Care Tissue-Based RAS Testing 8/5/2020

    Sysmex-Inostics, Inc., a global leader and pioneer in blood-based circulating tumor DNA (ctDNA) analysis for oncology, today announces the publication of a clinical study evaluating the performance of plasma RAS mutation testing with OncoBEAM RAS CRC as compared to standard of care tissue-based RAS testing in the United Kingdom (UK)